Avricore Health (AVCRF) Cash from Discontinued Operations (2019)
Avricore Health (AVCRF) posted quarterly Cash from Discontinued Operations of 58325.1 for Q4 2019, down 610.94% sequentially from 11415.19 in Q3 2019.
Avricore Health (AVCRF) Cash from Discontinued Operations (2019) Analysis & Trends
Avricore Health has disclosed Cash from Discontinued Operations across 1 years of filings, most recently posting 58325.1 for Q4 2019.
- In Q4 2019, Cash from Discontinued Operations changed N/A year-over-year to 58325.1; the TTM figure through Dec 2019 stood at 131179.81 (changed N/A YoY), while the FY2019 annual figure was 132592.37, up 154.66% from the prior year.
- Cash from Discontinued Operations slipped to 58325.1 in Q4 2019, from 11415.19 in the prior quarter.
- Over the last five years, Cash from Discontinued Operations for AVCRF reached as high as 125881.08 in Q2 2019 and fell as low as 58325.1 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -58,325.10 |
| Dec 31, 2019 | -58,325.10 |
| Sep 30, 2019 | 11,415.19 |
| Sep 30, 2019 | 11,415.19 |
| Jun 30, 2019 | 125,881.08 |
| Jun 30, 2019 | 125,881.08 |
| Mar 31, 2019 | 52,208.65 |
| Mar 31, 2019 | 52,208.65 |